Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vincerx Pharma Inc.

    NASDAQ: VINC · Real-Time Price · USD
    0.05
    -0.00 (-1.96%)
    At close: Jun 09, 2025, 12:40 PM

    Vincerx Pharma Statistics

    Share Statistics

    Vincerx Pharma has 5.23M shares outstanding. The number of shares has increased by 51.66% in one year.

    Shares Outstanding

    n/a
    		 5.23M

    Shares Change (YoY)

    n/a
    		 51.66%

    Shares Change (QoQ)

    n/a
    		 22.83%

    Owned by Institutions (%)

    n/a
    		 0.03%

    Shares Floating

    n/a
    		 4.67M

    Failed to Deliver (FTD) Shares

    n/a
    		 205

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 2K, so 0.04% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2K

    Short % of Shares Out

    n/a
    		 0.04%

    Short % of Float

    n/a
    		 0.04%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.33 and the forward PE ratio is -0.01. Vincerx Pharma's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.33

    Forward PE

    n/a
    		 -0.01

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 3.67

    P/FCF Ratio

    n/a
    		 -0.38

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vincerx Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.21, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 1.21

    Quick Ratio

    n/a
    		 1.21

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,506,166.67

    Employee Count

    n/a
    		 12

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -99.65% in the last 52 weeks. The beta is 1.48, so Vincerx Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.48

    52-Week Price Change

    n/a
    		 -99.65%

    50-Day Moving Average

    n/a
    		 0.18

    200-Day Moving Average

    n/a
    		 4.77

    Relative Strength Index (RSI)

    n/a
    		 32.44

    Average Volume (20 Days)

    n/a
    		 826,320

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -31.46M

    Net Income

    n/a
    		 -30.07M

    EBITDA

    n/a
    		 -31.46M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -15.85
    Full Income Statement

    Balance Sheet

    The company has 4.99M in cash and 0 in debt, giving a net cash position of 4.99M.

    Cash & Cash Equivalents

    n/a
    		 4.99M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -189.19M

    Total Assets

    n/a
    		 4.69M

    Working Capital

    n/a
    		 2.07M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -26.13M and capital expenditures 0, giving a free cash flow of -26.13M.

    Operating Cash Flow

    n/a
    		 -26.13M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -26.13M

    FCF Per Share

    n/a
    		 -13.77
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    VINC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VINC is $40, which is 79900% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $40

    Price Target Difference

    n/a
    		 79900%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 28, 2025. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jan 28, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -76.67

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist